» Articles » PMID: 36366935

Metacognition Vulnerabilities in Time of Crisis: Who to Protect from Suicidal Risk?

Overview
Journal Brain Behav
Specialty Psychology
Date 2022 Nov 11
PMID 36366935
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: During stressful events, we are all trying to cope. We may not be equal depending on our emotional, psychological, and mental states. During the COVID-19 pandemic, we could try to avoid negative information processing and anxiogenics content to prevent unhealthy thinking processes. One of the processes we can observe regarding our way of thinking and its impact on our psychological well-being is Metacognition.

Methods: We recruited 104 outpatients in 2018. In 2020, during the pandemic, we recruited 216 outpatients and 176 healthy controls. We assessed their level of metacognition with the MCQ30 scale together with Suicidal risk and Hopelessness.

Results: All three groups showed significant differences, with the nonclinical sample having higher scores in MCQ30. Regression revealed the different profiles where Hopelessness was the only predictor for the clinical sample, whereas metacognition was an adjunctive predictor of suicidal risk for the nonclinical sample.

Conclusion: Our results showed that the COVID-19 crisis influenced metacognitive levels for the nonclinical sample but not for the clinical population. Moreover, Hopelessness predicted suicide risk for both populations, but Metacognition was also a predictive factor for the nonclinical sample. We conclude with the possible impact of preventive measures based on Metacognitive work that can be created out of these results.

Citing Articles

Metacognition vulnerabilities in time of crisis: Who to protect from suicidal risk?.

Martin S, Oltra A, Del Monte J Brain Behav. 2022; 12(12):e2794.

PMID: 36366935 PMC: 9759143. DOI: 10.1002/brb3.2794.

References
1.
Sher L . The impact of the COVID-19 pandemic on suicide rates. QJM. 2020; 113(10):707-712. PMC: 7313777. DOI: 10.1093/qjmed/hcaa202. View

2.
Normann N, Morina N . The Efficacy of Metacognitive Therapy: A Systematic Review and Meta-Analysis. Front Psychol. 2018; 9:2211. PMC: 6246690. DOI: 10.3389/fpsyg.2018.02211. View

3.
Moritz S, Vitzthum F, Randjbar S, Veckenstedt R, Woodward T . Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatry. 2010; 23(6):561-9. DOI: 10.1097/YCO.0b013e32833d16a8. View

4.
Bouvard M, Charles S, Guerin J, AIMARD G, Cottraux J . [Study of Beck's hopelessness scale. Validation and factor analysis]. Encephale. 1992; 18(3):237-40. View

5.
Fisher P, Byrne A, Fairburn L, Ullmer H, Abbey G, Salmon P . Brief Metacognitive Therapy for Emotional Distress in Adult Cancer Survivors. Front Psychol. 2019; 10:162. PMC: 6365419. DOI: 10.3389/fpsyg.2019.00162. View